RNA-seq counts + paired clinical metadata are invaluable for R&D but carry re-identification risks and are locked behind DUAs and IRBs.
Synthetic RNA-seq cohorts are a candidate fix - but how well do they work at transcriptome scale?
biorxiv.org/content/10.64898…
With @somdutta12
Validated synthetic RNA-seq cohorts, as a complement to controlled-access real data, can enable exploratory analysis/testing instead of waiting months for DUA/IRBs.
Faster science and fewer failed access requests. All benchmark code open at github.com/Nanda-Aditya/rna-…
In our new study, we reconcile prominent, and sometimes competing, explanations for the nature and origin of scale-free neural activity in systems neuroscience. doi.org/10.1016/j.celrep.202…
Collectively, our study simplifies and unifies existing explanations of scale-free brain activity. It also provides new, stringent tests on future theories that seek to transcend these explanations.
Thank you to all collaborators! Graham Johnson, Yu Mu (@muyuuyum), Misha Ahrens (@MishaAhrens), Catie Chang (@cately00), Dario Englot (@Englot), Michael Breakspear (@DrBreaky), and Mika Rubinov (@mika_rubinov)
4
961
Aditya Nanda retweeted
If you leave your dog in the car, make sure you leave the windows cracked enough for me to get my hand in there to pet them.



